Caris Life Sciences (CAI)
Delivers tissue and blood molecular profiling for oncology care and biopharma research.
$31.35
vs last close−0.12 (−0.39%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 54.11% | 152.91M shares | |
|---|---|---|---|
| 257 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 54.97% | 155.33M shares | |
| 15 holders · as of Sep 17, 2026 | |||
| Strategic holders | 14.62% | 41.33M shares | |
| 2 holders · as of Jun 23, 2025 | |||
| Adds to | 123.70% | ||
282.60M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
These groups come from separate filings that can overlap, so they add to 123.70%; nothing is left for Other.
13F, as of Jun 30, 2026
257 holders · 152.91M shares · 72 new positions · 177 increased · 48 reduced · 25 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| FMR LLC | 30.92M | 10.94% | +138.3K | Aug 13, 2026 |
| J. H. Whitney Equity Partners Vi, LLC | 11.26M | 3.98% | −7.00M | Aug 12, 2026 |
| Coatue Management LLC | 9.82M | 3.47% | 0 | Aug 14, 2026 |
| Braidwell LP | 8.26M | 2.92% | +246.6K | Aug 14, 2026 |
| Sixth Street Partners Management Company, L.P. | 7.33M | 2.59% | −7.06M | Aug 14, 2026 |
| Pointstate Capital LP | 6.83M | 2.42% | −531.6K | Aug 14, 2026 |
| JPMorgan Chase & Co | 6.56M | 2.32% | +3.10M | Aug 12, 2026 |
| BlackRock, Inc. | 5.54M | 1.96% | +679.7K | Aug 7, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| David D. Halbert | 44.10% | 124.91M | 13G | Aug 13, 2025 |
| FMR LLC | 10.80% | 30.63M | 13G | Apr 7, 2026 |
| TSSP Sub-Fund HoldCo, LLC | 8.30% | 23.17M | 13G | Jul 28, 2025 |
| J H Whitney VI LP | 7.30% | 20.26M | 13G | Aug 14, 2025 |
| J H Whitney VI L P | 6.50% | 18.26M | 13G | May 12, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 17, 2026 | Brian J. Brilledirector, officer: See Remarks | Sale | 400,000 | $30.33 | 230,303 |
| Sep 4, 2026 | David Baxley Spetzlerofficer: President | Sale | 119,212 | $24.76 | 1,182,871 |
| Sep 3, 2026 | David Baxley Spetzlerofficer: President | Sale · 2 lots | 478,000 | $24.86 | 1,052,083 |
| May 15, 2026 | Jon Halbertdirector | Purchase | 68,000 | $14.56 | 704,598 |
| May 11, 2026 | Jeff L. Vacircadirector | Purchase | 31,050 | $16.15 | 49,671 |
| Dec 11, 2025 | Luke Thomas Powerofficer: See Remarks | Sale · 2 lots | 62,250 | $26.58 | 99,571 |
| Nov 7, 2025 | David Baxley Spetzlerofficer: President | Purchase | 400 | $23.85 | 460,777 |
| Nov 7, 2025 | John Russel Dentonofficer: See Remarks | Purchase | 4,184 | $24.09 | 9,184 |
House and Senate disclosures
Not reported.